Establishing a cGMP pancreatic islet processing facility: the first experience in Iran
- 240 Downloads
It has been predicted that one of the greatest increase in prevalence of diabetes will happen in the Middle East bear in the next decades. The aim of standard therapeutic strategies for diabetes is better control of complications. In contrast, some new strategies like cell and gene therapy have aimed to cure the disease. In recent years, significant progress has occurred in beta-cell replacement therapies with a progressive improvement of short-term and long term outcomes. In year 2005, considering the impact of the disease in Iran and the promising results of the Edmonton protocol, the funding for establishing a current Good Manufacturing Practice (cGMP) islet processing facility by Endocrinology and Metabolism Research Center was approved by Tehran University of Medical Sciences. Several islet isolations were performed following establishment of cGMP facility and recruitment of all required equipments for process validation and experimental purpose. Finally the first successful clinical islet isolation and transplantation was performed in September 2010. In spite of a high cost of the procedure it is considered beneficial and may prevent long term complications and the costs associated with secondary cares. In this article we will briefly describe our experience in setting up a cGMP islet processing facility which can provide valuable information for regional countries interested to establish similar facilities.
KeywordsClean room Clinical grade cGMP Pancreatic islet
The authors would like to thank, Dr. Eghbal Taheri, Dr. Hossein Adibi, Dr. Mohamad Reza Amini, Bahman Dellalat, Mozhgan Hassanpour, Fereshteh Mohamadi- Jahani and Firozeh Ghaderi for their kindly collaboration. Also we acknowledge Dr. Amir Hossein Tavakoli, Dr. Abbas Khodadadi, Dr.Sanaz Dehghani, Niloufar Tirgar, Dr. Hassan Bahrami-nasab, and the other staff of organ procurement units of Iranian Tissue Bank and Sina Hospital.
- Larijani B, Maleckzadeh H, Pajoohi M et al (2003) Prevalence of diabetes mellitus & impaired glucose tolerance of population aged over 25 in Qazvin. J Qazvin Univ Med Sci 26:41–45Google Scholar
- Rezagholizadeh A, Heshmat R, Larijani B (2007) Iranian diabetes guidelines: methods and objectives. Iran J Diabetes Lipid Disord 7(1):115–120Google Scholar
- Shapiro J (2002) Eighty years after insulin: parallels with modern islet transplantation. JAMC 167(12):1398–1400Google Scholar